Get started
Author

Elke Maria van Veen

Observed names: E. van Veen, EM van Veen, Elke M van Veen, Elke M. Van Veen, Elke M. Veen, Elke M. van Veen, Elke Van Veen, Elke van Veen, Elke M. van Veen, Van Veen, E.M., Van Veen, Elke, Van Veen, Elke M, Van Veen, Elke M., Veen, Elke M. Van, van Veen, E.M., van Veen, Elke, van Veen, Elke M, van Veen, Elke M.
Observed institutions: National Institutes of Health, Radboud University Nijmegen, University of Cologne, University of Cambridge, Manchester Academic Health Science Centre, Universitair Ziekenhuis Leuven, Herlev Hospital, Copenhagen University Hospital, Radboud University Medical Center, Karolinska Institutet, University of Manchester, St Mary's Hospital, Manchester University NHS Foundation Trust, Stockholm South General Hospital, National Institute of Environmental Health Sciences, St Mary's Hospital, The Christie NHS Foundation Trust, National Cancer Institute, University Hospital Cologne, NIHR Manchester Biomedical Research Centre, Division of Cancer Epidemiology and Genetics, Cancer Research UK Manchester Centre, Radboud Institute for Health Sciences, KU Leuven
ORCID: 0000-0001-8618-2332
Observed ORCID: 0000-0001-8618-2332
OpenAlex ID: A5046674130
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
2018 · Nasim Mavaddat, Kyriaki Michailidou, et al. · The American Journal of Human Genetics · 1,097
PDF
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
2020 · Haoyu Zhang, Thomas U. Ahearn, et al. · Nature Genetics · 501
PDF
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction
2018 · Elke M. van Veen, Adam R. Brentnall, et al. · JAMA Oncology · 140
PDF
Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
2018 · Xiang Shu, Lang Wu, et al. · International Journal of Epidemiology · 109
PDF
A Dominantly Inherited 5′ UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer
2018 · D.Gareth R. Evans, Elke M. van Veen, et al. · The American Journal of Human Genetics · 94
PDF
Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries
2021 · Amber N Wilcox, Parichoy Pal Choudhury, et al. · International Journal of Epidemiology · 75
PDF
Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel
2022 · D. Gareth R. Evans, Elke M. van Veen, et al. · Genetics in Medicine · 68
PDF
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
2019 · D. Gareth R. Evans, Elaine F. Harkness, et al. · Breast Cancer Research and Treatment · 68
PDF
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
2020 · Iris Kramer, Maartje J. Hooning, et al. · The American Journal of Human Genetics · 66
PDF
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk
2020 · Pooja Middha Kapoor, Nasim Mavaddat, et al. · JNCI Journal of the National Cancer Institute · 65
PDF
Genome-wide association study of germline variants and breast cancer-specific mortality
2019 · NBCS Collaborators, Maria Escala-Garcia, et al. · British Journal of Cancer · 62
A case–control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density
2019 · Adam R. Brentnall, Elke M. van Veen, et al. · International Journal of Cancer · 59
PDF
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
2019 · Gisella Figlioli, Massimo Bogliolo, et al. · npj Breast Cancer · 44
PDF
The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
2021 · D. Gareth Evans, Elke M. van Veen, et al. · International Journal of Cancer · 40
Common variants in breast cancer risk loci predispose to distinct tumor subtypes
2022 · Thomas U. Ahearn, Haoyu Zhang, et al. · Breast Cancer Research · 33
PDF
Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk
2013 · Polat Dura, Elke M. van Veen, et al. · International Journal of Cancer · 29
Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testing
2016 · Helen Byers, Yvonne Wallis, et al. · European Journal of Human Genetics · 27
The impact of coding germline variants on contralateral breast cancer risk and survival
2023 · Anna Morra, Nasim Mavaddat, et al. · The American Journal of Human Genetics · 26
PDF
High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer
2021 · D Gareth Evans, Elke Maria van Veen, et al. · Journal of Medical Genetics · 26
PDF
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
2021 · Hanla A. Park, Sonja Neumeyer, et al. · British Journal of Cancer · 22
PDF
Transmission of molecularly undetectable circulating parasite clones leads to high infection complexity in mosquitoes post feeding
2018 · Lynn Grignard, Bronner P. Gonçalves, et al. · International Journal for Parasitology · 22
PDF
Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women
2021 · D. Gareth Evans, Sacha J. Howell, et al. · Breast Cancer Research and Treatment · 21
PDF
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
2023 · Gisella Figlioli, Amandine Billaud, et al. · European Journal of Human Genetics · 15
EPICURE: Ensemble Pretrained Models for Extracting Cancer Mutations from Literature
2021 · Jiarun Cao, Elke M van Veen, et al. · IEEE International Symposium on Computer-Based Medical Systems (CBMS) · 15
PDF
Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer
2021 · Emma R. Woodward, Elke M. van Veen, et al. · Genetics in Medicine · 14
Works count: 69
Citation count: 2,848
H-index: 21
I10-index: 29
Year
Topic
Type